CA19-9 epitopes have been detected specifically on mucin glycoproteins mucin 5AC and mucin 16 in patient populations with PDAC, detection of which bolsters the performance of cancer identification when combined with clinically used CA19-9 panels (42). This evidence concerns the gene MUC16 and cancer.